FINKELSTEIN J J 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Jul 9, 2018
Insider Transaction Report
Form 4
FINKELSTEIN J J
DirectorPresident and CEO
Transactions
- Conversion
Convertible Promissory Note (right to buy)
2018-07-05−104,456→ 0 totalExercise: $0.06From: 2013-07-05Exp: 2018-07-04→ Common Stock (104,456 underlying) - Conversion
Common Stock
2018-07-05$0.06/sh+104,456$6,267→ 1,637,991 total
Footnotes (1)
- [F1]The Convertible Promissory Note in the principal amount of $5,000 accrued $1,267.36 in interest and both principal and interest were converted into 104,456 shares of common stock at a conversion price of $0.06 per share.